BALAXI PHARMACEUTICALS LTD.

NSE : BALAXIBSE : ISIN CODE : INE618N01014Industry : TradingHouse : Private
BSE0.000 (0 %)
PREV CLOSE ( ) NA
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.00 0.00
52 WK LOW / HIGH ( )0 0
NSE495.957.05 (+1.44 %)
PREV CLOSE( ) 488.90
OPEN PRICE ( ) 508.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 10638
TODAY'S LOW / HIGH( ) 482.75 518.70
52 WK LOW / HIGH ( )399.95 686.3
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax569.22545.22443.2987.9424.39
Adjustment80.3411.81-5.920.330.05
Changes In working Capital-467.88-159.66-411.39-221.19-39.41
Cash Flow after changes in Working Capital181.69397.3725.98-132.92-14.97
Cash Flow from Operating Activities60.75341.450.03-140.36-15.07
Cash Flow from Investing Activities-105.65-284.48-59.73-1.83-0.05
Cash Flow from Financing Activities255.13-1.6336.46180.96NA
Net Cash Inflow / Outflow210.2255.33-23.2438.77-15.12
Opening Cash & Cash Equivalents71.9016.5639.801.0316.15
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange FluctuationsNANANANANA
Closing Cash & Cash Equivalent282.1271.9016.5639.801.03

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.